Olema Pharmaceuticals earnings were -$142.3M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest OLMA earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$43.8M, up 44.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OLMA reported annual earnings of -$129.5M, with 34% growth.
Olema Pharmaceuticals Earnings Reports & History FAQ
What were Olema Pharmaceuticals's earnings last quarter?
On OLMA's earnings call on Invalid Date, Olema Pharmaceuticals (NASDAQ: OLMA) reported Q2 2025 earnings per share (EPS) of -$0.51, up 5.56% year over year. Total OLMA earnings for the quarter were -$43.78 million. In the same quarter last year, Olema Pharmaceuticals's earnings per share (EPS) was -$0.54.
Is Olema Pharmaceuticals profitable or losing money?
As of the last Olema Pharmaceuticals earnings report, Olema Pharmaceuticals is currently losing money. Olema Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$142.30 million, a 29.8% increase year over year.
What was OLMA's earnings growth in the past year?
As of Olema Pharmaceuticals's earnings date in Invalid Date, Olema Pharmaceuticals's earnings has grown year over year. OLMA earnings in the past year totalled -$142.30 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.